Phase II Study of the Anti-Cytotoxic T-Lymphocyte–Associated Antigen 4 Monoclonal Antibody, Tremelimumab, in Patients With Refractory Metastatic Colorectal Cancer
CHUNG, Ki Y, GORE, Ira, SALTZ, Leonard B, FONG, Lawrence, VENOOK, Alan, BECK, Stephen B, DORAZIO, Prudence, CRISCITIELLO, Peggy J, HEALEY, Diane I, BO HUANG, GOMEZ-NAVARRO, Jesus
Published in Journal of clinical oncology (20.07.2010)
Published in Journal of clinical oncology (20.07.2010)
Get full text
Journal Article
Dasatinib in imatinib‐resistant or ‐intolerant chronic‐phase, chronic myeloid leukemia patients: 7‐year follow‐up of study CA180‐034
Shah, Neil P., Rousselot, Philippe, Schiffer, Charles, Rea, Delphine, Cortes, Jorge E., Milone, Jorge, Mohamed, Hesham, Healey, Diane, Kantarjian, Hagop, Hochhaus, Andreas, Saglio, Giuseppe
Published in American journal of hematology (01.09.2016)
Published in American journal of hematology (01.09.2016)
Get full text
Journal Article
382 Targeting innate immunity with BXCL701 in combination with pembrolizumab in patients with advanced solid cancers: phase 2 basket study
Janku, Filip, Tsimberidou, Apostolia, Holley, Veronica, Adat, Abha, Karakuzu, Ozgur, Call, Greg, Urschel, Gabriele, Healey, Diane, O’Neill, Vincent
Published in Journal for immunotherapy of cancer (01.11.2020)
Published in Journal for immunotherapy of cancer (01.11.2020)
Get full text
Journal Article
Randomized Phase II Study of BR96-Doxorubicin Conjugate in Patients With Metastatic Breast Cancer
TOLCHER, A. W, SUGARMAN, S, GELMON, K. A, COHEN, R, SALEH, M, ISAACS, C, YOUNG, L, HEALEY, D, ONETTO, N, SLICHENMYER, W
Published in Journal of clinical oncology (01.02.1999)
Published in Journal of clinical oncology (01.02.1999)
Get full text
Journal Article
Phase I Trial of the Anti–Lewis Y Drug Immunoconjugate BR96-Doxorubicin in Patients With Lewis Y–Expressing Epithelial Tumors
Saleh, M N, Sugarman, S, Murray, J, Ostroff, J B, Healey, D, Jones, D, Daniel, C R, LeBherz, D, Brewer, H, Onetto, N, LoBuglio, A F
Published in Journal of clinical oncology (01.06.2000)
Published in Journal of clinical oncology (01.06.2000)
Get full text
Journal Article
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
Hellmann, Matthew D, Ciuleanu, Tudor-Eliade, Pluzanski, Adam, Lee, Jong Seok, Otterson, Gregory A, Audigier-Valette, Clarisse, Minenza, Elisa, Linardou, Helena, Burgers, Sjaak, Salman, Pamela, Borghaei, Hossein, Ramalingam, Suresh S, Brahmer, Julie, Reck, Martin, O’Byrne, Kenneth J, Geese, William J, Green, George, Chang, Han, Szustakowski, Joseph, Bhagavatheeswaran, Prabhu, Healey, Diane, Fu, Yali, Nathan, Faith, Paz-Ares, Luis
Published in The New England journal of medicine (31.05.2018)
Published in The New England journal of medicine (31.05.2018)
Get full text
Journal Article
Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)
Horn, Leora, Spigel, David R, Vokes, Everett E, Holgado, Esther, Ready, Neal, Steins, Martin, Poddubskaya, Elena, Borghaei, Hossein, Felip, Enriqueta, Paz-Ares, Luis, Pluzanski, Adam, Reckamp, Karen L, Burgio, Marco A, Kohlhäeufl, Martin, Waterhouse, David, Barlesi, Fabrice, Antonia, Scott, Arrieta, Oscar, Fayette, Jérôme, Crinò, Lucio, Rizvi, Naiyer, Reck, Martin, Hellmann, Matthew D, Geese, William J, Li, Ang, Blackwood-Chirchir, Anne, Healey, Diane, Brahmer, Julie, Eberhardt, Wilfried E E
Published in Journal of clinical oncology (10.12.2017)
Published in Journal of clinical oncology (10.12.2017)
Get full text
Journal Article
Long-term outcome with dasatinib after imatinib failure in chronic-phase chronic myeloid leukemia: follow-up of a phase 3 study
Shah, Neil P., Guilhot, François, Cortes, Jorge E., Schiffer, Charles A., le Coutre, Philipp, Brümmendorf, Tim H., Kantarjian, Hagop M., Hochhaus, Andreas, Rousselot, Philippe, Mohamed, Hesham, Healey, Diane, Cunningham, Michael, Saglio, Giuseppe
Published in Blood (10.04.2014)
Published in Blood (10.04.2014)
Get full text
Journal Article
Phase 1 dose‐escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinoma
Rini, Brian I., Stein, Mark, Shannon, Pat, Eddy, Simantini, Tyler, Allison, Stephenson, Joe J., Catlett, Lorie, Huang, Bo, Healey, Diane, Gordon, Michael
Published in Cancer (15.02.2011)
Published in Cancer (15.02.2011)
Get full text
Journal Article
BXCL701, first-in-class oral activator of systemic innate immunity pathway, combined with pembrolizumab (Keytruda) in men with metastatic castration-resistant prostate cancer (mCRPC)
Aggarwal, Rahul Raj, Costin, Dan, Zhang, Jingsong, Karsh, Lawrence Ivan, Healey, Diane I., Linch, Mark David, Adurthi, Sreenivas, Petrylak, Daniel Peter, O'Neill, Vince, Monk, Paul
Published in Journal of clinical oncology (20.02.2021)
Published in Journal of clinical oncology (20.02.2021)
Get full text
Journal Article
Safety of BXCL701, a small molecule inhibitor of dipeptidyl peptidases (DPP), with pembrolizumab, (pembro, anti-PD-1) monoclonal antibody, in men with metastatic castration-resistant prostate cancer (mCRPC)
Aggarwal, Rahul Raj, Costin, Dan, O'Neill, Vincent J., Burg, Cedric R, Healey, Diane I., De Bono, Johann S., Zhang, Jingsong, Small, Eric Jay
Published in Journal of clinical oncology (20.02.2020)
Published in Journal of clinical oncology (20.02.2020)
Get full text
Journal Article
Targeting innate immunity with BXCL701 in combination with pembrolizumab in patients with advanced solid cancers: Phase 2 basket study
Karakuzu, Ozgur, Tsimberidou, Apostolia Maria, Holley, Veronica R., Adat, Abha, Patel, Sapna Pradyuman, Sood, Anil K., Conley, Anthony Paul, Urschel, Gabriele E, Healey, Diane I., O'Neill, Vincent, Janku, Filip
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Phase 1b study of BXCL701, a novel small molecule inhibitor of dipeptidyl peptidases (DPP), combined with pembrolizumab (pembro), in men with metastatic castration-resistant prostate cancer (mCRPC)
Aggarwal, Rahul Raj, Costin, Dan, O'Neill, Vincent J., Corsi-Travali, Stefani, Adurthi, Sreenivas, Adedoyin, Adedayo, Healey, Diane I., De Bono, Johann S., Monk, Paul, Zhang, Jingsong, Small, Eric Jay
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Abstract CT077: Nivolumab (nivo) + ipilimumab (ipi) vs platinum-doublet chemotherapy (PT-DC) as first-line (1L) treatment (tx) for advanced non-small cell lung cancer (NSCLC): initial results from CheckMate 227
Hellmann, Matthew D., Ciuleanu, Tudor Eliade, Pluzanski, Adam, Lee, Jong Seok, Otterson, Gregory, Audigier-Valette, Clarisse, Minenza, Elisa, Linardou, Helena, Burgers, Sjaak, Salman, Pamela, Borghaei, Hossein, Ramalingam, Suresh S., Brahmer, Julie, Reck, Martin, O'Byrne, Kenneth J., Geese, William J., Green, George, Chang, Han, Szustakowski, Joseph D., Bhagavatheeswaran, Prabhu, Healey, Diane, Fu, Yali, Nathan, Faith, Paz-Ares, Luis
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
International Laboratory Comparison of Methodologies for Determining Minimal Residual Disease (MRD) in Childhood Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
Reshmi, Shalini C., Stonerock, Eileen, Borowitz, Michael J., Geese, William J, Healey, Diane, Gastier-Foster, Julie M., Hunger, Stephen P., Biondi, Andrea, Cazzaniga, Giovanni
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
CA180-372: An International Collaborative Phase 2 Trial of Dasatinib and Chemotherapy in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
Hunger, Stephen P., Saha, Vaskar, Devidas, Meenakshi, Grazia Valsecchi, Maria, Gastier Foster, Julie, Cazzaniga, Gianni, Reshmi, Shalini C., Borowitz, Michael, Moorman, Anthony, Heerema, Nyla A., Carroll, Andrew J., Barnette, Phillip, Gramatges, M. Monica Monica, Maloney, Kelly, Sun, Weili, Swanink, Rene, Termuhlen, Amanda, Loh, Mignon L., Raetz, Elizabeth A., Silverman, Lewis B., Schrappe, Martin, Schultz, Kirk R., Slayton, William, Healey, Diane, Biondi, Andrea
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Long-term efficacy and safety of dasatinib in patients with chronic myeloid leukemia in accelerated phase who are resistant to or intolerant of imatinib
Ottmann, Oliver, Saglio, Giuseppe, Apperley, Jane F., Arthur, Christopher, Bullorsky, Eduardo, Charbonnier, Aude, Dipersio, John F., Kantarjian, Hagop, Khoury, Hanna Jean, Kim, Dong-Wook, Healey, Diane, Strauss, Lewis, Cortes, Jorge E.
Published in Blood cancer journal (New York) (03.09.2018)
Published in Blood cancer journal (New York) (03.09.2018)
Get full text
Journal Article
Seven-Year (yr) Follow-up of Patients (pts) with Imatinib-Resistant or -Intolerant Chronic-Phase Chronic Myeloid Leukemia (CML-CP) Receiving Dasatinib in Study CA180-034, Final Study Results
Shah, Neil P., Rousselot, Philippe, Schiffer, Charles A., Rea, Delphine, Cortes, Jorge E., Milone, Jorge, Mohamed, Hesham, Healey, Diane, Kantarjian, Hagop, Hochhaus, Andreas, Saglio, Giuseppe
Published in Blood (06.12.2014)
Published in Blood (06.12.2014)
Get full text
Journal Article
OA03.05 Analysis of Early Survival in Patients with Advanced Non-Squamous NSCLC Treated with Nivolumab vs Docetaxel in CheckMate 057
Peters, Solange, Cappuzzo, Frederico, Horn, Leora, Paz-Ares, Luis, Borghaei, Hossein, Barlesi, Fabrice, Steins, Martin, Felip, Enriqueta, Spigel, David, Dorange, Cécile, Lu, Haolan, Healey, Diane, Kong Sanchez, Teresa, Bhagavatheeswaran, Prabhu, Novotny, James, Lestini, Brian, Brahmer, Julie
Published in Journal of thoracic oncology (01.01.2017)
Published in Journal of thoracic oncology (01.01.2017)
Get full text
Journal Article